High-dose atorvastatin after stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators

J Cardiometab Syndr. 2008 Winter;3(1):68-9. doi: 10.1111/j.1559-4572.2008.07967.x.

Authors

Stroke Prevetion by Aggressive Reduction in Cholestrol Levels (SPARCL) Investigators¹; Jocelyne G Karam, Lisel Loney-Hutchinson, Samy I McFarlane

Affiliation

¹ State University of New York Health Science Center and Kings County Hospital Center, Brooklyn, NY, USA.

PMID: 18326981
DOI: 10.1111/j.1559-4572.2008.07967.x

No abstract available

MeSH terms

Adult
Atorvastatin
Cardiovascular Diseases / prevention & control
Cerebral Hemorrhage
Cerebral Infarction / prevention & control
Cholesterol, LDL / blood
Drug Therapy, Combination
Female
Heptanoic Acids / administration & dosage*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
Ischemic Attack, Transient / drug therapy*
Male
Pyrroles / administration & dosage*
Randomized Controlled Trials as Topic
Recurrence
Risk
Stroke / drug therapy*
Stroke / mortality

Substances

Cholesterol, LDL
Heptanoic Acids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pyrroles
Atorvastatin